Interleukin-1 beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1

Citation
T. Hellwig-burgel et al., Interleukin-1 beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1, BLOOD, 94(5), 1999, pp. 1561-1567
Citations number
43
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
94
Issue
5
Year of publication
1999
Pages
1561 - 1567
Database
ISI
SICI code
0006-4971(19990901)94:5<1561:IBATNF>2.0.ZU;2-C
Abstract
The rate of transcription of several genes encoding proteins involved in O- 2 and energy homeostasis is controlled by hypoxia-inducible factor-1 (HIF-1 ), a heterodimeric DNA binding complex composed of alpha and beta subunits. HIF-1 is considered the primary trans-acting factor for the erythropoietin (EPO) and vascular endothelial growth factor (VEGF) genes. Since EPO gene expression is inhibited by the proinflammatory cytokines interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha), while no such eff ect has been reported with respect to the VEGF gene, we investigated the ef fects of IL-1 beta and TNF-alpha on the activation of the HIF-1 DNA-binding complex and the amount of HIF-1 alpha protein in human hepatoma cells in c ulture. Under normoxic conditions, both cytokines caused a moderate activat ion of HIF-1 DNA binding. In hypoxia, cytokines strongly increased HIF-1 ac tivity compared with the effect of hypoxia alone, Only IL-1 beta increased HIF-1 alpha. protein levels. In transient transfection experiments, HIF-1-d riven reporter gene expression was augmented by cytokines only under hypoxi c conditions. In contrast to their effect on EPO synthesis, neither IL-1 be ta nor TNF-alpha decreased VEGF production. The mRNA levels of HIF-1 alpha and VEGF were unaffected. Thus, cytokine-induced inhibition of EPO producti on is not mediated by impairment of HIF-1 function. We propose that HIF-1 m ay be involved in modulating gene expression during inflammation. (C) 1999 by The American Society of Hematology.